Acquired, non-amyloid related factor X deficiency: Review of the literature

Haemophilia

Volumn 18, Issue 5, 2012, Pages 655-663

  Lee, G ^a   Duan Porter, W ^a   Metjian, A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acquired coagulopathy; Acquired factor X deficiency; Coagulopathy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMSACRINE; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; FRESH FROZEN PLASMA; GLUCOCORTICOID; HEMOGLOBIN; IMMUNOGLOBULIN; METHYL BROMIDE; PREDNISONE; PROTHROMBIN COMPLEX; VALPROIC ACID;

ACUTE SINUSITIS; AGED; AMYLOIDOSIS; ANEMIA; ARM SWELLING; BLEEDING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CASE REPORT; COMPARTMENT SYNDROME; DISEASE ASSOCIATION; DRUG EXPOSURE; ECCHYMOSIS; HAND PARESTHESIA; HEMOPHILIA; HUMAN; INFECTION; MALE; PARTIAL THROMBOPLASTIN TIME; PLASMA CELL DYSCRASIA; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SKIN BRUISING;

AGED; AMYLOIDOSIS; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR X; FACTOR X DEFICIENCY; HUMANS; MALE; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 84865574569     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02773.x     Document Type: Review

References (50)

1. Mertens K, Bertina RM. Pathways in the activation of human coagulation factor X. Biochem J 1980; 185: 647-58.
2. Bom VJ, Bertina RM. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem J 1990; 265: 327-36.
3. Crockett CL, Shotton D, Craddock C, Leavell BS. Hypoprothrombinemia: studies of a case of the idiopathic type and the effect of serum administration. Blood 1949; 4: 1298-309.
4. Telfer TP, Denson KW, Wright DR. A new coagulation defect. Br J Haematol 1956; 2: 308-16.
5. Hougie C, Barrow EM, Graham JB. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 1957; 36: 485-96.
6. Wright IS. The nomenclature of blood clotting factors. Can Med Assoc J 1962; 86: 373-4.
7. Dewerchin M, Liang Z, Moons L et al. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 2000; 83: 185-90.
8. Acharya SS, Coughlin A, Dimichele DM. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-56.
9. Karimi M, Yarmohammadi H, Ardeshiri R. Inherited coagulation disorders in southern Iran. Haemophilia 2002; 8: 740-4.
10. Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999; 82: 1207-14.
11. Korsan-Bengtsen K, Hjort PF, Ygge J. Acquired factor X deficiency in a patient with amyloidosis. Thromb Diath Haemorrh 1962; 7: 558-66.
12. Takabe K, Holman PR, Herbst KD, Glass CA, Bouvet M. Successful perioperative management of factor X deficiency associated with primary amyloidosis. J Gastrointest Surg 2004; 8: 358-62.
13. Thompson CA, Kyle R, Gertz M, Heit J, Pruthi R, Pardanani A. Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients. Am J Hematol 2010; 85: 171-3.
14. Mumford AD, O'Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 2000; 110: 454-60.
15. Gupta N, Dadhwal V, Deka D, Jain SK, Mittal S. Corpus luteum hemorrhage: rare complication of congenital and acquired coagulation abnormalities. J Obstet Gynaecol Res 2007; 33: 376-80.
16. Fair DS, Plow EF, Edgington TS. Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest 1979; 64: 884-94.
17. Uprichard J, Perry DJ. Factor X deficiency. Blood Rev 2002; 16: 97-110.
18. Fair DS, Edgington TS. Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses. Br J Haematol 1985; 59: 235-48.
19. Baudo F, Redaelli R, Caimi MT et al. Acquired selective factor X (FX) deficiency in acute non lymphoyctic leukemia (ANLL) [Abstract #1134]. Thromb Diath Haemorrh 1989; 62: 364.
20. Caimi MT, Redaelli R, Cattaneo D, Nosari AM, Baudo F, de Cataldo F. Acquired selective factor X deficiency in acute nonlymphocytic leukemia. Am J Hematol 1991; 36: 65-6.
21. Hsia CC, Keeney M, Bosco AA, Xenocostas A. Treatment of acquired factor X inhibitor by plasma exchange with concomitant intravenous immunoglobulin and corticosteroids. Am J Hematol 2008; 83: 318-20.
22. Smith SV, Liles DK, White GC 2nd, Brecher ME. Successful treatment of transient acquired factor X deficiency by plasmapheresis with concomitant intravenous immunoglobulin and steroid therapy. Am J Hematol 1998; 57: 245-52.
23. Henson K, Files JC, Morrison FS. Transient acquired factor X deficiency: report of the use of activated clotting concentrate to control a life-threatening hemorrhage. Am J Med 1989; 87: 583-5.
24. Edgin RA, Metz EN, Fromkes JJ, Beman FM. Acquired factor X deficiency with associated defects in platelet aggregation. A response to corticosteroid therapy. Am J Med 1980; 69: 137-9.
25. Hosker JP, Jewell DP. Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP. Postgrad Med J 1983; 59: 514-5.
26. Currie MS, Stein AM, Rustagi PK, Behrens AN, Logue GL. Transient acquired factor X deficiency associated with pneumonia. N Y State J Med 1984; 84: 572-3.
27. Ashrani AA, Aysola A, Al-Khatib H, Nichols WL, Key NS. Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications. Br J Haematol 2003; 121: 639-42.
28. Peuscher FW, van Aken WG, van Mourik JA, Swaak AJ, Sie LH, Statius van Eps LW. Acquired, transient factor X (Stuart factor) deficiency in patient with mycoplasma pneumonial infection. Scand J Haematol 1979; 23: 257-64.
29. Mulhare PE, Tracy PB, Golden EA, Branda RF, Bovill EG. A case of acquired factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against factor X. Am J Clin Pathol 1991; 96: 196-200.
30. Bayer WL, Borek D, Chandramohan M, Jenkins DC, Plapp FV. Acquired Idiopathic factor X deficiency [Abstract]. Blood 1982; 1982: 207A.
31. Kyriakou DS, Alexandrakis MG, Passam FH et al. Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol 2002; 14: 1383-7.
32. Ness PM, Hymas PG, Gesme D, Perkins HA. An unusual factor-X inhibitor in leprosy. Am J Hematol 1980; 8: 397-402.
33. Eiser AR, Zilversmit R, Neff MS, Grishman E, Slifkin RF. Progressive systemic sclerosis with the nephrotic syndrome and acquired factor X deficiency. Am J Nephrol 1986; 6: 61-5.
34. Haberal M, Basaran O, Sakallioglu AE, Kesik E, Alioglu B, Ozbek N. Acquired-transient factor X deficiency associated with anticardiolipin antibodies in a child with extensive burns. J Burn Care Res 2006; 27: 113-6.
35. Matsunaga AT, Shafer FE. An acquired inhibitor to factor X in a pediatric patient with extensive burns. J Pediatr Hematol Oncol 1996; 18: 223-6.
36. Korte W, Flury R. Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy. Ann Hematol 1992; 64: 152-4.
37. Stefanini M, Wiggishoff CC. Stuart factor (factor X) deficiency associated with renal and adrenal cortical insufficiency. Ann Intern Med 1966; 64: 1285-91.
38. Pabinger I, Bettelheim P, Dudczak R et al. Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia. Ann Hematol 1991; 62: 174-9.
39. Gallais V, Bredoux H, le Roux G, Laroche L. Acquired and transient factor X deficiency associated with sodium valproate treatment. Eur J Haematol 1996; 57: 330.
40. Carter C, Winfield DA. Factor X deficiency during treatment of relapsed acute myeloid leukaemia with amsacrine. Clin Lab Haematol 1988; 10: 225-8.
41. Graham J, Barrow E, Wynne T. Stuart Clotting Defect. III. An Acquired Case With Complete Recovery. Chapel Hill: University of North Carolina Press, 1959.
42. Bayer WL, Curiel D, Szeto IL, Lewis JH. Acquired factor X deficiency in a Negro boy. Pediatrics 1969; 44: 1007-9.
43. Rao LV, Zivelin A, Iturbe I, Rapaport SI. Antibody-induced acute factor X deficiency: clinical manifestations and properties of the antibody. Thromb Haemost 1994; 72: 363-71.
44. Lankiewicz MW, Bell WR. A unique circulating inhibitor with specificity for coagulation factor X. Am J Med 1992; 93: 343-6.
45. Blanks H. Gross hematuria and easy bruising in a young man. J Tenn Med Assoc 1993; 86: 156.
46. Bayer WL, Borek D, Chandramohan M, Jenkins DC, Plapp FV. Acquired idiopathic factor X deficiency [Abstract]. Blood 1982; 60(Suppl.): 207A.
47. Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency. Haematologica 2008; 93: 934-8.
48. Peyvandi F, Mannucci PM, Lak M et al. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998; 102: 626-8.
49. Sallah S, Nguyen NP, Abdallah JM, Hanrahan LR. Acquired hemophilia in patients with hematologic malignancies. Arch Pathol Lab Med 2000; 124: 730-4.
50. Toor AA, Slungaard A, Hedner U, Weisdorf DJ, Key NS. Acquired factor VII deficiency in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2002; 29: 403-8.